Infrrd Announces the Official Launch of Ally: The First Agentic AI Workforce for Mortgage Auditing 
Blockpass and RWA Inc. Partner to Effect Verifiable Trust in Real World Asset & DePIN Tokenization 
AITX’s RAD Reports One of Its Strongest Multi-Client Single-Day Order Intake Totals Chinook Therapeutics to Present at Upcoming Investor Conferences
SEATTLE, April 08, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…
Baudax Bio Announces Partial Adjournment of Annual Meeting of Shareholders
Annual Meeting to be adjourned solely with respect to Proposal 3 MALVERN, Pa., April 08,…
10x Genomics to Report First Quarter Financial Results on May 5, 2021
PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) — 10x Genomics (Nasdaq: TXG) today announced it…
Vascular Biogenics Ltd. Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
TEL AVIV, Israel, April 08, 2021 (GLOBE NEWSWIRE) — Vascular Biogenics Ltd. (“VBL Therapeutics” or…
Chimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021
DURHAM, N.C., April 08, 2021 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating…
Extension of lock-up period in Gilead-Galapagos collaboration agreement
Mechelen, Belgium; 08 April 2021; 22.01 CET; Galapagos (Euronext & Nasdaq; GLPG) announced today…
Onxeo to Present New Preclinical Data at AACR 2021
Confirming the effect of AsiDNA™ on resistance to KRAS inhibitors Introducing OX400, a new generation…
Tricida to Present at the Needham Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA) today announced…
Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)
BOSTON, April 08, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company…
22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee
Another key indicator and milestone of the Increasing Importance of Reducing Cigarette Nicotine Content as…
NTG Nordic Transport Group A/S – Annual General Meeting 2021
Company announcement no 14 – 218 April 2021 NTG Nordic Transport Group A/S – Annual…
Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling Platform
NEW YORK, NY, and REHOVAT, ISRAEL, April 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical,…
Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women
NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) — Last Chance for Children’s (LCFC) Mission is…
Golden Leaf Holdings Completes Eighty Percent Acquisition of Plant-Based CBD Skincare Brand, Fifth & Root
PORTLAND, Ore., April 08, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden…
Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy
APX3330 has the Potential to be a Novel Oral Treatment Option with Dual Mechanism of Anti-VEGF…
Vir Biotechnology Announces New Research Demonstrating Novel Mechanisms by Which SARS-CoV-2 Enters Host Cells
– Growing body of evidence suggests monoclonal antibodies that target a conserved epitope have the potential…
Medolife Rx Announces Positive Pre-Clinical Results Showing Up to 95 Percent Cancer Cell Apoptosis with Introduction of Lead Cancer Drug Candidate
BURBANK, Calif., April 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…
Mereo BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference
LONDON and REDWOOD City, Calif., April 08, 2021 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc…
Ceapro Inc. Announces Successful Completion of Collaborative Research and Development Program with University of Alberta
– Project significantly advances broadening the application and utility of Ceapro’s proprietary, first-in-class technologies to…
Auris Medical to Provide Business Update on AM-301 Program on Tuesday, April 13, 2021
Hamilton, Bermuda, April 8, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company…